• Blog
  • Drug Screening Market Growth Analysis | 2023-2028

    Drug Screening Market Growth Analysis | 2023-2028

    Drug Screening Market Growth Analysis | 2023-2028
    Report code - SRHL219 Delivery - 2 Weeks
    Drug Screening Market Size, Share, Trends, Dynamics, Forecast, and Growth Analysis - 2023- See more...

    Market Insights

    The drug screening market was estimated at USD 6.13 billion in 2022 and is likely to grow at a CAGR of 16.7% during 2023-2028 to reach USD 15.52 billion in 2028.

    Drug-Screening-Market-Insights

    Wish to get a free sample? Click here.

    What is drug screening?

    Drug screening is defined as the process of collecting and analyzing blood, hair, urine, or saliva to detect the presence of contaminants and chemicals left in the body as a result of drug consumption. In this process, potential drugs are identified and optimized before selecting a candidate drug for a clinical trial. Drug screening is done in order to determine if a person is or has consumed drugs at a certain point in time.

    COVID-19 IMPACT

    The covid-19 outbreak affected the growth of the drug screening market for a short period of time due to disruption in business and economic activities across geographies. Postponement of non-essential medical services amid the covid-19 outbreak also affected the growth of the drug screening market. However, with the reopening of the economy, the market is likely to experience growth during the review period.

    Drug Screening Market Highlights

    Market Size in 2022

    USD 6.13 billion

    Market Size in 2028

    USD 15.52 billion

    Market Growth (2023-2028)

    16.7% CAGR

    Base Year of Study

    2022

    Trend Period

    2017-2021

    Forecast Period

    2023-2028

    Market Dynamics

    Increasing drug and alcohol testing measures in various countries to curb the menace of drug and alcohol abuse is likely to drive market growth significantly.

    • The market growth is primarily driven by an increase in the consumption of drugs and alcohol across the geographies, particularly among the youth and elderly population.
    • The players operating in the market are emphasizing product innovation to strengthen their market presence and attain a competitive edge over other market players.

    Drug-Screening-Market-Dynamics

    Want to have a closer look at this report, Download a free sample

    Segment Analysis

    End User Type

    The workplace segment accounted for the largest market share in 2022.

    Based on end users, the market has been divided into workplaces, criminal justice systems, law enforcement agencies, drug treatment centers, pain management centers, drug testing laboratories, and others. The segment growth can be attributed to a rising safety concern for the staff.

    Regional Insights

    The market in North America accounted for the largest share in 2022 due to the high consumption of drugs and alcohol. Additionally, supporting government measures to curb the use of drugs is likely to add significantly to the market growth. The market in Europe accounted for the second-largest market share in 2022.

    Drug-Screening-Market-Regional-Insights

    Want to know which region offers the best growth opportunities then, Click Here.

    Critical Questions answered in this report-

    • What are the key trends in the market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the market?
    • What are the key strategies adopted by the major vendors to lead in the market?
    • What is the market share of the top vendors?

    Market Segmentation

    This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.

    The market is segmented into the following categories.

    By Product & Services Type

    • Analytical Instruments
    • Rapid Testing Devices
    • Consumables
    • Drug Screening Services

    By Sample Type

    • Urine Samples
    • Breath Samples
    • Oral Fluid Samples
    • Hair Samples
    • Others

    By End User Type

    • Workplace
    • Criminal Justice Systems, and Law Enforcement Agencies
    • Drug Treatment Centers
    • Pain Management Centers
    • Drug Testing Laboratories
    • Others

    By Region

    • North America (Country Analysis: the USA, Canada, and Mexico) 
    • Europe (Country Analysis: Germany, France, the UK, Russia, Spain, and the Rest of Europe)
    • Asia-Pacific (Country Analysis: China, Japan, India, South Korea, and the Rest of Asia-Pacific)
    • Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)

    Drug-Screening-Market-Segmentation

    Want to know the most attractive market segments? Register Here

    Key Players

    Key players operating in the drug screening market are-

    • Alere Inc. (The U.S),
    • Laboratory Corporation of America Holdings (The U.S),
    • OraSure Technologies (The U.S),
    • Quest Diagnostics (The U.S),
    • Thermo Fisher Scientific (The U.S),
    • Alfa Scientific Designs, Inc. (The U.S),
    • MPD Inc. (The U.S),
    • Lifeloc Technologies, Inc. (The U.S),
    • Omega Laboratories Inc. (The U.S),
    • Sciteck Diagnostics Inc (The U.S),
    • ACM GLOBAL LABORATORIES (The U.S), and
    • Carehealth America Corporation (The U.S).

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

    More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.

    We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

    Report Features

    This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

    What Deliverables Will You Get in this Report?

    Key questions this report answers

    Relevant contents in the report

    How big is the sales opportunity?

    In-depth Analysis of the Drug Screening Market

    How lucrative is the future?

    Market forecast and trend data and emerging trends

    Which regions offer the best sales opportunities?

    Global, regional, and country-level historical data and forecasts

    Which are the most attractive market segments?

    Market Segment Analysis and Forecast

    Which are the top players and their market positioning?

    Competitive landscape analysis, Market share analysis

    How complex is the business environment?

    Porter’s five forces analysis, PEST analysis, Life cycle analysis

    What are the factors affecting the market?

    Drivers & challenges

    Will I get the information on my specific requirements?

    10% free customization

    Report Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to 3 players)
    • SWOT analysis of key players (up to 3 players)

    Market Segmentation

    • Current market segmentation by any one of the product & services types by end-user type.

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    The drug screening market size is expected to reach USD 15.52 billion in the foreseeable future.

    Alere Inc. (The U.S), Laboratory Corporation of America Holdings (The U.S), OraSure Technologies (The U.S), Quest Diagnostics (The U.S), Thermo Fisher Scientific (The U.S), Alfa Scientific Designs, Inc. (The U.S), MPD Inc. (The U.S), Lifeloc Technologies, Inc. (The U.S), Omega Laboratories Inc. (The U.S), Sciteck Diagnostics Inc (The U.S), ACM GLOBAL LABORATORIES (The U.S), and Carehealth America Corporation (The U.S) are among the key players in the market.

    The market is expected to grow at an impressive CAGR of 16.7% in the coming years.

    North America accounted for the largest share of the market in 2022.

    The workplace segment accounted for the largest share of the market in 2022.

    Increasing drug and alcohol testing measures in various countries to curb the menace of drug and alcohol abuse, an increase in consumption of drugs and alcohol across the geographies, particularly among the youth and elder population are the factors driving the growth of the market.

    Drug screening distributors, Drug screening suppliers, Drug screening manufacturers, Logistics organizations, and Government Bodies are the target audience in the market.